- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
NEW YORK ( TheStreet) -- United Therapeutics Corporation (Nasdaq: UTHR) hit a new 52-week high Tuesday as it is currently trading at $56.38, above its previous 52-week high of $56.24 with 7,747 shares traded as of 9:30 a.m. ET. Average volume has been 658,300 shares over the past 30 days. United has a market cap of $2.79 billion and is part of the health care sector and drugs industry. Shares are up 14.3% year to date as of the close of trading on Monday. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. The company has a P/E ratio of 11.2, above the average drugs industry P/E ratio of 11.1 and below the S&P 500 P/E ratio of 17.7.